Opportunity Information: Apply for CDC RFA PS13 1303
Apply for CDC RFA PS13 1303
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Viral Hepatitis Prevention and Surveillance" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.270 Adult Viral Hepatitis Prevention and Control.
- This funding opportunity was created on Jun 12, 2012 and posted on Jun 12, 2012.
- Applicants must submit their applications by Aug 13, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $15,600,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $350,000.00 in funding.
- The number of recipients for this funding is limited to 55 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Applicants Category A, Part 1 and Category B The following entities are eligible to apply For Category A, Part 1 Viral Hepatitis Prevention Coordinator State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, and the Virgin Islands) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov. For Category B Surveillance State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov. Limited competition for this RFA is justified based on the following In 2010, IOM, in its report titled, Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C, cited viral hepatitis as a large and underappreciated health issue for the nation. The IOM articulated ways to improve prevention and care services and called for an intensified, coordinated national prevention and health care effort. In response, HHS developed the Viral Hepatitis Action Plan, which set prevention goals, established program priorities, and assigned responsibilities for actions to meet priorities to HHS operating divisions, including CDC. To implement activities outlined in the plan, CDC will provide funds in the FOA for FY 2013 2015 to help state and local health departments implement or sustain prevention and surveillance activities.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The CDC funding opportunity titled "Viral Hepatitis Prevention and Surveillance" (Funding Opportunity Number CDC RFA PS13-1303) is a discretionary cooperative agreement designed to help state and local health departments advance the HHS Viral Hepatitis Action Plan. The core intent is twofold: first, to strengthen viral hepatitis prevention efforts by increasing testing and improving access to care and treatment, and second, to improve surveillance capacity so health departments can better detect and respond to hepatitis transmission and disease trends. In practical terms, the opportunity is aimed at supporting public health systems that can identify people at risk or already infected, connect them to clinical services, and build stronger data systems to understand where infections are occurring and how patterns are changing.
A major emphasis of the program is alignment with Healthy People 2020 Immunization and Infectious Diseases objectives, especially those focused on reducing hepatitis B and hepatitis C infections and improving awareness and vaccination coverage in higher-risk groups. The grant is tied to targets such as reducing or maintaining elimination of new hepatitis B cases among youth ages 2 to 18, increasing hepatitis B vaccine coverage among high-risk populations, and reducing hepatitis B infections among adults 19 and older. It also highlights priority populations disproportionately affected by hepatitis B, including people who inject drugs and men who have sex with men. For hepatitis C, it supports efforts to reduce new infections and increase the percentage of people who know they are infected, reflecting the public health importance of expanding testing and diagnosis. The notice also references reducing tuberculosis (TB) as part of the broader Healthy People 2020 infectious disease framework listed in the announcement.
The award structure indicates CDC anticipated approximately 55 awards, with an estimated total funding level of about $15.6 million. Individual awards were expected to range from $120,000 (floor) to $350,000 (ceiling), and there was no cost sharing or matching requirement. The funding instrument is a cooperative agreement, which typically means recipients would carry out the work while collaborating closely with CDC on program direction, technical assistance, and performance expectations. The activity category is listed as health, and the CFDA number associated with the program is 93.270 (Adult Viral Hepatitis Prevention and Control).
Eligibility was limited primarily to state and local governments, including the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands, as well as bona fide agents authorized to apply on behalf of these governments. A bona fide agent application required formal, legally binding documentation from the relevant state or local government confirming that status, submitted with the application materials. The opportunity is described as limited competition, justified by the national strategy context: the Institute of Medicine's 2010 report "Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C" characterized viral hepatitis as a large but underrecognized U.S. health problem and called for a coordinated national response. HHS then created the Viral Hepatitis Action Plan, and this CDC funding was positioned as a way to implement or sustain key prevention and surveillance activities at the state and local level during the FY 2013 to 2015 period.
Key administrative details include an original posting date of June 12, 2012, with an application closing date of August 13, 2012, and an archive date of September 12, 2012. For assistance accessing the full announcement, CDC listed its Procurement and Grants Office as the contact point (phone 770-488-2700; email pgotim@cdc.gov).
Frequently Asked Questions (FAQs): CDC Viral Hepatitis Prevention and Surveillance (CDC RFA PS13-1303)
What is this CDC funding opportunity?
This opportunity is the CDC discretionary cooperative agreement titled "Viral Hepatitis Prevention and Surveillance" under Funding Opportunity Number CDC RFA PS13-1303. It is intended to help state and local health departments advance the HHS Viral Hepatitis Action Plan through strengthened prevention activities and improved surveillance capacity.
What are the main goals of the program?
The program has two core goals: (1) strengthen viral hepatitis prevention by increasing testing and improving access to care and treatment, and (2) improve surveillance capacity so health departments can better detect and respond to hepatitis transmission and disease trends.
What kinds of activities does the opportunity aim to support in practice?
In practical terms, it aims to support public health systems that can identify people at risk or already infected, connect them to clinical services, and build stronger data systems to understand where infections are occurring and how patterns are changing.
How does this opportunity relate to the HHS Viral Hepatitis Action Plan?
The cooperative agreement is positioned as a way to implement or sustain key prevention and surveillance activities at the state and local level in support of the HHS Viral Hepatitis Action Plan.
How does this opportunity align with Healthy People 2020 objectives?
A major emphasis is alignment with Healthy People 2020 Immunization and Infectious Diseases objectives. The announcement highlights objectives focused on reducing hepatitis B and hepatitis C infections, improving awareness, and increasing vaccination coverage in higher-risk groups.
Which hepatitis B priorities are emphasized?
The notice ties the grant to targets such as reducing or maintaining elimination of new hepatitis B cases among youth ages 2 to 18, increasing hepatitis B vaccine coverage among high-risk populations, and reducing hepatitis B infections among adults ages 19 and older.
Which populations are specifically noted as priorities for hepatitis B?
The announcement highlights priority populations disproportionately affected by hepatitis B, including people who inject drugs and men who have sex with men.
Which hepatitis C priorities are emphasized?
For hepatitis C, the opportunity supports efforts to reduce new infections and increase the percentage of people who know they are infected, reflecting a focus on expanding testing and diagnosis.
Does the announcement mention any other infectious diseases besides viral hepatitis?
Yes. The notice references reducing tuberculosis (TB) as part of the broader Healthy People 2020 infectious disease framework listed in the announcement.
What type of award is this?
The funding instrument is a cooperative agreement. This typically means recipients carry out the work while collaborating closely with CDC on program direction, technical assistance, and performance expectations.
How many awards did CDC anticipate making?
CDC anticipated approximately 55 awards.
What was the estimated total funding level?
The estimated total funding level was about $15.6 million.
What was the expected funding range per award?
Individual awards were expected to range from $120,000 (floor) to $350,000 (ceiling).
Was cost sharing or matching required?
No. The announcement specifies there was no cost sharing or matching requirement.
What is the activity category for this program?
The activity category is listed as health.
What CFDA number is associated with this opportunity?
The CFDA number associated with the program is 93.270 (Adult Viral Hepatitis Prevention and Control).
Who was eligible to apply?
Eligibility was limited primarily to state and local governments, including the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands, as well as bona fide agents authorized to apply on behalf of these governments.
What is a "bona fide agent" in the context of this opportunity?
A bona fide agent is an entity authorized to apply on behalf of a state or local government. The announcement notes that a bona fide agent application required formal, legally binding documentation from the relevant government confirming that status, submitted with the application materials.
Was this a competitive grant opportunity?
The opportunity is described as limited competition.
Why was the competition limited?
The limited competition is justified in the announcement by the national strategy context. It references the Institute of Medicine's 2010 report "Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C," which characterized viral hepatitis as a large but underrecognized U.S. health problem and called for a coordinated national response. HHS then created the Viral Hepatitis Action Plan, and this funding was positioned to support state and local implementation during FY 2013 to 2015.
What were the key dates for this funding opportunity?
The original posting date was June 12, 2012. The application closing date was August 13, 2012. The archive date was September 12, 2012.
Who was the CDC contact for help with the full announcement?
For assistance accessing the full announcement, CDC listed its Procurement and Grants Office as the contact point: phone 770-488-2700; email pgotim@cdc.gov.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Aquatic Invasive Species in the Southwest
Previous opportunity: Assessment of ecological roles of gravel bar features restored by gravel augmentation and channel rehabilitation activities below Lewiston Dam
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS13 1303
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS13 1303) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research Resource for Human Organs and Tissues (U42) Apply for RFA OD 12 002 Funding Number: RFA OD 12 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health and Humanitarian Assistance Service Delivery Grants Apply for APS 294 12 000001 Funding Number: APS 294 12 000001 Agency: West Bank, Gaza USAID West Bank Category: Health Funding Amount: $10,000,000 |
| Decreasing Patient Radiation Dose from CT Imaging Achieving Sub mSv Studies (U01) Apply for PAR 12 206 Funding Number: PAR 12 206 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Renal Function and Chronic Kidney Disease in Aging (R21) Apply for PA 12 210 Funding Number: PA 12 210 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Human Heredity and Health in Africa (H3Africa) Ethical, Legal, and Societal Issues (ELSI) Research Program (U01) Apply for RFA RM 12 005 Funding Number: RFA RM 12 005 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| PPHF 2012 Nutrition, Physical Activity and Obesity Programs financed in part by 2012 Prevention and Public Health Funds Apply for CDC RFA DP08 8050501PPHF12 Funding Number: CDC RFA DP08 8050501PPHF12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Obesity Prevention Programs Statewide Collaboratives to Improve Nutrition, Breastfeeding Support, Physical Activity and Screen Time Practices for Obesity Prevention in Young Children financed solely by 2012 Prevention and Public Health Funds Apply for CDC RFA DP12 1215PPHF12 Funding Number: CDC RFA DP12 1215PPHF12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Advancing Partners Community based Family Planning Project Apply for SOL OAA 12 000091 Funding Number: SOL OAA 12 000091 Agency: Agency for International Development Category: Health Funding Amount: $210,000,000 |
| Sustainable, Community Action and Leadership Enhancement towards Universal Health Care (UHC) through Clinical and Organizational Capacity Strengthening of Midwives for Maternal, Neonatal, Child Health and Nutrition (MNCHN SCALE UP) Apply for RFA 492 12 000004 Funding Number: RFA 492 12 000004 Agency: Agency for International Development Category: Health Funding Amount: $1,500,000 |
| Integrative Medicine Program (IMP) Apply for HRSA 12 180 Funding Number: HRSA 12 180 Agency: Health Resources and Services Administration Category: Health Funding Amount: $150,000 |
| National coordinating center for Integrative Medicine Apply for HRSA 12 182 Funding Number: HRSA 12 182 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| PPHF 2012 Breast and Cervical Cancer Screening Opportunities for States, Tribes and Territories Financed solely by 2012 Prevention and Public Health Funds Apply for CDC RFA DP12 1218PPHF12 Funding Number: CDC RFA DP12 1218PPHF12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $700,000 |
| Partner Support for Heart Disease and Stroke Prevention Apply for CDC RFA DP12 1213 Funding Number: CDC RFA DP12 1213 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Biobehavioral Research Awards for Innovative New Scientists (BRAINS) (R01) Apply for RFA MH 13 110 Funding Number: RFA MH 13 110 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Florida Greater Orlando Area) Apply for PA FPH 12 030 Funding Number: PA FPH 12 030 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $584,240 |
| Community Health Projects Related to Contamination at Land Reuse and Brownfield Sites Apply for CDC RFA TS12 1202 Funding Number: CDC RFA TS12 1202 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Development of Medical Countermeasures for Post Exposure Mitigation/Treatment of Injuries Resulting from a Radiation/Nuclear Incident (U01) Apply for RFA AI 12 023 Funding Number: RFA AI 12 023 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| PPHF 2012 Breastfeeding Promotion and Support Hospital Collaboratives to Improve Maternity Care Practices Related to Breastfeeding in the U.S. Financed solely by 2012 Prevention and Public Health Funds Apply for CDC RFA DP11 111602PPHF12 Funding Number: CDC RFA DP11 111602PPHF12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Affordable Care Act Health Center Controlled Networks Apply for HRSA 13 237 Funding Number: HRSA 13 237 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Program Grants to Nonprofit Organizations Apply for HRSA 12 163 Funding Number: HRSA 12 163 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS13 1303", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.